Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIg in Recurrent Implantation Failure
NCT03174964Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jul 2016
- Primary completion
- Feb 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of immune globulin in Recurrent Implantation Failure (RIF), sponsored by Tabriz University of Medical Sciences. Started Jul 2016; status: completed.
02
Drugs
immune globulin
03
Conditions
Recurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT03174964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03174964.